FIELD: virology and veterinary.
SUBSTANCE: disclosed is vaccine for protection of horses, dogs, cats, cattle, hog and birds from West Nile encephalitis virus. Vaccine contains one or more recombinant bird smallpox viruses NYVAC or MVA and expresses prM, M and E proteins of West Nile encephalitis virus.
EFFECT: improved against from West Nile encephalitis virus.
22 cl, 1 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT BLUETONGUE VACCINE | 2007 |
|
RU2446823C2 |
RECOMBINANT VACCINE OF FELINE LEUKEMIA VIRUS CONTAINING OPTIMISED GENE OF FELINE LEUKEMIA VIRAL ENVELOPE | 2012 |
|
RU2591817C2 |
COMPOSITIONS OF RECOMBINANT CDV AND ITS USE | 2011 |
|
RU2567337C2 |
RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CTLA-4 OR FELINE CD86 AND ITS APPLYING | 1999 |
|
RU2244006C2 |
DNA PLASMIDS SHOWING HIGH EXPRESSION AND STABILITY | 2007 |
|
RU2456346C2 |
CHIMERIC FLAVIVIRAL VACCINES | 1998 |
|
RU2209082C2 |
PLASMID WITHOUT RESISTANCE TO ANTIBIOTIC | 2010 |
|
RU2548809C2 |
FMDV VACCINES BASED ON A RECOMBINANT ADENOVIRAL VECTOR AND USE THEREOF | 2017 |
|
RU2725495C2 |
PASSAGE VECTOR AND VACCINE FOR TUBERCULOSIS | 2007 |
|
RU2453603C2 |
BACULOVIRUS VECTOR AND USE THEREOF | 2007 |
|
RU2588464C2 |
Authors
Dates
2006-09-10—Published
2002-04-05—Filed